WKN: | A12FU4 |
ISIN: | US92346J1088 |
Land: | USA |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Biotechnologie |
EQS-News: ABIVAX / Key word(s): Capital Increase Abivax Announces Closing of $747.5 Million Public Offering 28.07.2025 / 22:15 CET/CEST The issuer is solely responsible ...weiterlesen